Evidence map›Paper›PMID 26563141›Full record

Observational studyBMC infectious diseases2015

About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli.

Jean-Ralph Zahar, Laurent Poirel, Claire Dupont, Nicolas Fortineau, Xavier Nassif, Patrice Nordmann

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Common findings of blaCurrent microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jean-Ralph ZaharInfection Control Unit, CHU Angers, Angers, France. JeanRalph.Zahar@chu-angers.fr.
Laurent PoirelService de Bactériologie - Hygiène, Hôpital de Bicêtre, K.-Bicêtre, France. laurent.poirel@unifr.ch.
Claire DupontService de Bactériologie - Hygiène, Hôpital de Bicêtre, K.-Bicêtre, France. claire.dupont@gmail.com.
Nicolas FortineauService de Bactériologie - Hygiène, Hôpital de Bicêtre, K.-Bicêtre, France. nicolas.fortineau@yahoo.fr.
Xavier NassifService de Microbiologie-Hygiène, Hôpital Necker-Enfants-Malades, Paris, France. x.nassif@yahoo.fr.
Patrice NordmannService de Bactériologie - Hygiène, Hôpital de Bicêtre, K.-Bicêtre, France. patrice.nordmann@unifr.ch.
Bicêtre Hospital · FRHôpital Necker-Enfants Malades · FRUniversity of Fribourg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtended-spectrum β-lactamases producing Escherichia coli (ESBL-E) are increasingly identified in health care facilities. As previously done for the control of methicillin-resistant Staphylococcus aureus, many hospitals have established screening strategies for early identification of patients being carriers of ESBL producers in general and ESBL-E in particular, and have implemented contact precautions (CP) for infected and colonized patients.

methodsThe incidence of ESBL-E has been compared retrospectively between two French university hospitals (A and B) with different infection control policies over a 5-year long period of time (2006-2010).

resultsWhile hospital A only implemented standard precautions after identification of patients colonized with ESBL-E, hospital B recommended additional CP. During the period of the study, the ESBL-E incidence rate significantly increased in both hospitals, but no significant difference was observed between the two hospitals.

conclusionsThis observational study did not reveal that additional CP measures had a greater impact on the incidence of ESBL-E in hospital settings.

Indexed as

beta-Lactamasesbeta-Lactam ResistanceCarrier StateChildCross InfectionEnterobacteriaceaeEscherichia coliEscherichia coli InfectionsFemaleHospitals, UniversityHumansIncidenceInfection ControlMaleMiddle AgedParisbeta-Lactamases

Identifiers

PMID26563141
PMCPMC4642679
OpenAlexW2115704805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.